RLAY
RLAY clinical trials: Relay Therapeutics, Inc.
Every trial on ClinicalTrials.gov where Relay Therapeutics, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 7
- Trials linked
- 5
- As lead sponsor
- 2
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
RLAY on the catalyst calendar · RLAY registry changes
- Primary completion Jul 2031Sponsor estimatePhase 2NCT06789913A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and...Relay Therapeutics, Inc. · PIK3CA-Related Overgrowth Spectrum (PROS)RecruitingRLAYLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 30, 2028Sponsor estimatePhase 3NCT06982521Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant...Relay Therapeutics, Inc. · PIK3CA MutationRecruitingRLAYLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 31, 2029Sponsor estimatePhase 1/Phase 2NCT07584226A First-in-human Study of RLY-8161 in Advanced NRAS-Mutant Solid TumorsRelay Therapeutics, Inc. · Advanced NRAS-Mutant MelanomaRecruitingRLAYLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 30, 2027Sponsor estimatePhase 1NCT05216432First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in...Relay Therapeutics, Inc. · PIK3CA MutationRecruitingRLAYLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 18, 2025ActualPhase 1NCT05759949First-in-Human Study of RLY-5836 in Advanced Breast Cancer and Other Solid TumorsRelay Therapeutics, Inc. · PIK3CA MutationCompletedRLAYLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 19, 2021ActualNo phase registeredNCT03402139Early Childhood Obesity Programming by Intrauterine Growth RestrictionMontefiore Medical Center · Childhood ObesityCompletedMRKCollaboratorRLAYCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 1, 2022ActualNo phase registeredNCT04622527A Study to Assess Virtual Reality by Healthcare Providers: A Pilot StudyMayo Clinic · AnxietyCompletedRLAYCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 7 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner